SELLAS Life Sciences
SLS
SLS
29 hedge funds and large institutions have $21.3M invested in SELLAS Life Sciences in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
6% less funds holding
Funds holding: 31 → 29 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Holders
29
Holding in Top 10
–
Calls
$3.98M
Puts
$2.01M
Top Buyers
| 1 | +$1.65M | |
| 2 | +$1.46M | |
| 3 | +$1.43M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$793K |
| 5 |
State Street
Boston,
Massachusetts
|
+$416K |
Top Sellers
| 1 | -$1.11M | |
| 2 | -$410K | |
| 3 | -$233K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$129K |
| 5 |
VF
Virtu Financial
New York
|
-$125K |